Market Research Logo

Biochip Market Analysis by Type, (DNA Chips, Lab-On-a-Chip, Protein Chips, Cancer Diagnosis and Treatment, Gene Expression, Single Nucleotide Polymorphism (SNP) Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Proteomics, Expression Profi

Biochip Market Analysis by Type, (DNA Chips, Lab-On-a-Chip, Protein Chips, Cancer Diagnosis and Treatment, Gene Expression, Single Nucleotide Polymorphism (SNP) Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening), by End Use (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes), and Segment Forecasts to 2024

Global biochips anticipated market to reach USD 25.84 billion by 2024, according to a new report by Grand View Research, Inc. Growing adoption of personalized medicine and rapid technological advancements in the biochips market along with high market demand from proteomic and genomic applications is expected to drive market growth.

Anticipated launch and commercialization of novel products for diagnosis and treatment including laboratory- and non-laboratory-based research are expected to further reinforce growth in demand. Improvements in accuracy, resolution, and preparation procedures for the technology coupled with reduction in costs of associated materials are expected to fuel growth over the forecast period.

Ongoing developments related to further miniaturization of biochips are expected to enhance their applicability and additional usage for genetic sequencing methodologies, such as cancer genomics. Their usage is also expected to aid reduction in the cost of genome profiling, which is a factor likely to drive demand for the next step of genetic analysis, i.e., protein expression analysis. Consequently, a growth in the number of such protein profiling studies is expected to directly fuel demand for genomic and proteomic labeling techniques through to 2024.

Further Key Findings From the Report Suggest:

DNA chips form the largest revenue-generating segment of the biochip applications. Major contribution to this share comes from usage in cancer diagnostics/treatment and drug discovery applications. DNA chips accounted for around a third of the global market revenue in 2015. The other notable contributing segments to application of biochips include gene expression, single nucleotide polymorphism genotyping, genomic studies, and agricultural biotechnology.

The market is expected to have a high potential for growth as the technology has numerous applications to aid the miniaturization of molecular biology and biochemical & chemical assays. Over time, such miniaturization is expected to benefit medical technologies in terms of cost and input requirements.

DNA chips, lab-on-a-chip, protein chips, and tissue & cell arrays find a number of uses in pharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostic centers, and other end users like point-of-care settings, forensic labs, blood banks, etc.

North America was the largest revenue-generating region and accounted for over 45%of total revenue in 2015. This can be attributed to by the presence of government initiatives for personalized patient care coupled with the availability of a very large installed base of genetic and proteomic profiling platforms across the U.S. High market usage of next-gen sequencing techniques for molecular diagnosis and treatment used with microfluidic techniques also add to the large share. Furthermore, cancer analysis projects in a number of academic and clinical research institutes are also responsible for the region’s large share.

Some key players operating in this industry include Abbott Laboratories; PerkinElmer, Inc.; GE Healthcare; Illumina, Inc.; Thermo Fisher Scientific, Inc.; Merck Millipore; Agilent Technologies, Inc.; Sigma-Aldrich Corporation; Fluidigm Corporation; and Bio-Rad Laboratories, Inc.


Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Biochip Industry Outlook
3.1 Market Segmentation
3.2 Market Size and Growth prospects, 2013 - 2024
3.3 Biochip Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increase in adoption of next-generation sequencing
3.3.1.2 Growing R&D in proteomics and genomics
3.3.1.3 Presence of an extensive drug-development pipeline
3.3.1.4 Increasing adoption of personalized medicine
3.3.1.5 Rapid technological advances in biochip technology
3.3.2 Market restraint analysis
3.3.2.1 High cost of manufacturing
3.4 Key Opportunities Prioritized,2015
3.6 Industry Analysis - Porter’s
3.7 Biochip PESTEL Analysis
Chapter 4 Biochip Type Outlook
4.1 Global Biochip Revenue Share, by Product, 2015 & 2024
4.2 DNA Chips, by Application
4.2.1 DNA chips market, 2013 - 2024 (USD Million)
4.2.2 Cancer diagnosis and treatment
4.2.2.1 Cancer diagnosis and treatment market, 2013 - 2024 (USD Million)
4.2.3 Gene expression
4.2.3.1 Gene expression market, 2013 - 2024 (US Million)
4.2.4 Single nucleotide polymorphism (SNP) genotyping
4.2.4.1 SNP genotyping market, 2013 - 2024 (USD Million)
4.2.5 Genomics
4.2.5.1 Genomics market, 2013 - 2024 (USD Million)
4.2.6 Drug discovery
4.2.6.1 Drug discovery market, 2013 - 2024 (USD Million)
4.2.7 Agricultural biotechnology
4.2.7.1 Agricultural biotechnology market, 2013 - 2024 (USD Million)
4.2.8 Others
4.2.8.1 Other markets, 2013 - 2024 (USD Million)
4.3 Lab-On-a-Chip, by Application
4.3.1 Lab-on-a-chip market, 2013 - 2024 (USD Million)
4.3.2 Clinical diagnostics
4.3.2.1 Clinical diagnostics market, 2013 - 2024 (USD Million)
4.3.3 Genomics
4.3.3.1 Genomics market, 2013 - 2024 (USD Million)
4.3.4 In vitro diagnosis (IVD) & point-of-care (POC)
4.3.4.1 IVD & POC market, 2013 - 2024 (USD Million)
4.3.5 Proteomics
4.3.5.1 Proteomics market, 2013 - 2024 (USD Million)
4.3.6 Drug discovery
4.3.6.1 Drug discovery market, 2013 - 2024 (USD Million)
4.3.7 Others
4.3.7.1 Others market, 2013 - 2024 (USD Million)
4.4 Protein Chips, by Application
4.4.1 Protein chips market, 2013 - 2024 (USD Million)
4.4.2 Proteomics
4.4.2.1 Proteomics market, 2013 - 2024 (USD Million)
4.4.3 Expression profiling
4.4.3.1 Expression profiling market, 2013 - 2024 (USD Million)
4.4.4 Diagnostics
4.4.4.1 Diagnostics market, 2013 - 2024 (USD Million)
4.4.5 High Throughput Screening (HTS)
4.4.5.1 HTS market, 2013 - 2024 (USD Million)
4.4.6 Drug discovery
4.4.6.1 Drug discovery market, 2013 - 2024 (USD Million)
4.4.7 Others
4.4.7.1 Others market, 2013 - 2024 (USD Million)
4.5 Others
4.5.1 Other market, 2013 - 2024 (USD Million)
4.5.2 Tissue arrays
4.5.2.1 Tissue arrays market, 2013 - 2024 (USD Million)
4.5.3 Cell arrays
4.5.3.1 Cell arrays market, 2013 - 2024 (USD Million)
Chapter 5 Biochip End-Use Outlook
5.1 Global Biochip Revenue Share by End Use, 2015 & 2024
5.2 Biotechnology and Pharmaceutical Companies
5.2.1 Biotechnology and pharmaceutical companies market, 2013 - 2024 (USD Million)
5.3 Hospitals and Diagnostics Centers
5.3.1 Hospitals and diagnostics centers market, 2013 - 2024 (USD Million)
5.4 Academic & Research Institutes
5.4.1 Academic & research institutes market, 2013 - 2024 (USD Million)
5.5 Others
5.5.1 Others market, 2013 - 2024 (USD Million)
Chapter 7 Biochip Regional Outlook
7.1 Global Biochip Revenue Share, By Region, 2015&2024
7.2 North America
7.2.1 North America biochip market, 2013 - 2024 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. biochip market, 2013 - 2024 (US Million)
7.2.3 Canada
7.2.3.1 Canada biochip market, 2013 - 2024 (US Million)
7.3 Europe
7.3.1 Europe biochip market, 2013 - 2024 (USD Million)
7.3.2 Germany
7.3.2.1 Germany biochip market, 2013 - 2024(USD Million)
7.3.3 UK
7.3.3.1 UK biochip market, 2013 - 2024 (US Million)
7.4 Asia Pacific
7.4.1 Asia Pacific biochip market, 2013 - 2024 (USD Million)
7.4.2 Japan
7.4.2.1 Japan biochip market, 2013 - 2024 (US Million)
7.4.3 China
7.4.3.1 China biochip market, 2013 - 2024 (US Million)
7.5 Latin America
7.5.1 Latin America biochip market, 2013 - 2024 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil biochip market, 2013 - 2024 (US Million)
7.6 MEA
7.6.1 MEA biochip market, 2013 - 2024 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa biochip market, 2013 - 2024 (USD Million)
Chapter 8 Competitive Landscape
8.1 Abbott Laboratories
8.1.1 Company overview
8.1.1 Financial performance
8.1.2 Product benchmarking
8.1.3 Strategic initiatives
8.2 Agilent Technologies, Inc.
8.2.1 Company overview
8.2.2 Financial performance
8.2.3 Product benchmarking
8.2.4 Strategic initiatives
8.3 PerkinElmer, Inc.
8.3.1 Company overview
8.3.2 Financial performance
8.3.3 Product benchmarking
8.3.4 Strategic initiatives
8.4 Fluidigm Corporation
8.4.1 Company overview
8.4.2 Financial performance
8.4.3 Product benchmarking
8.4.4 Strategic initiatives
8.5 Illumina, Inc.
8.5.1 Company overview
8.5.2 Financial performance
8.5.3 Product benchmarking
8.5.4 Strategic initiatives
8.6 GE Healthcare
8.6.1 Company overview
8.6.2 Financial performance
8.6.3 Product benchmarking
8.6.4 Strategic initiatives
8.7 Bio-Rad Laboratories, Inc.
8.7.1 Company overview
8.7.2 Financial performance
8.7.3 Product benchmarking
8.7.4 Strategic initiatives
8.8 Thermo Fisher Scientific, Inc.
8.8.1 Company overview
8.8.2 Financial performance
8.8.3 Product benchmarking
8.8.4 Strategic initiatives
8.9 LI-COR, Inc.
8.9.1 Company overview
8.9.2 Financial performance
8.9.3 Product benchmarking
8.9.4 Strategic initiatives
8.10 EMD Millipore
8.10.1 Company overview
8.10.2 Financial performance
8.10.3 Product benchmarking
8.10.4 Strategic initiatives
8.11 Sigma Aldrich Corporation
8.11.1 Company overview
8.11.2 Financial performance
8.11.3 Product benchmarking
8.11.4 Strategic initiatives
List of Tables
TABLE 1 Biochip - Industry snapshot & key buying criteria, 2013 - 2024
TABLE 2 Global biochip market estimates, by type, 2013 - 2015 (USD Million)
TABLE 3 Global biochip market forecasts, by type, 2016 - 2024 (USD Million)
TABLE 4 Global biochip market estimates, by end use, 2013 - 2015 (USD Million)
TABLE 5 Global biochip market forecasts, by end use, 2016 - 2024 (USD Million)
TABLE 6 Biochip market estimates, by region, 2013 - 2015 (USD Million)
TABLE 7 Biochip market forecast, by region, 2016 - 2024 (USD Million)
TABLE 8 Biochip key market driver analysis
TABLE 9 Biochip key market restraint analysis
TABLE 10 North America biochip market estimates, by type, 2013 - 2024 (USD Million)
TABLE 11 North America biochip market forecast, by type, 2016 - 2024 (USD Million)
TABLE 12 North America DNA chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 13 North America DNA chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 14 North America lab-on-a-chip market estimates, by application, 2013 - 2024 (USD Million)
TABLE 15 North America lab-on-a-chip market forecast, by application, 2016 - 2024 (USD Million)
TABLE 16 North America protein chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 17 North America protein chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 18 North America other market estimates, by application, 2013 - 2024 (USD Million)
TABLE 19 North America other market forecast, by application, 2016 - 2024 (USD Million)
TABLE 20 North America biochip market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 21 North America biochip market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 22 North America biotechnology and pharmaceutical companies market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 23 North America biotechnology and pharmaceutical companies market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 24 North America hospitals and diagnostics centers market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 25 North America hospitals and diagnostics centers market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 26 North America academic & research institutes market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 27 North America academic & research institutes market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 28 North America others market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 29 North America others market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 30 U.S. biochip market estimates, by type, 2013 - 2024 (USD Million)
TABLE 31 U.S. biochip market forecast, by type, 2016 - 2024 (USD Million)
TABLE 32 U.S. DNA chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 33 U.S. DNA chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 34 U.S. lab-on-a-chip market estimates, by application, 2013 - 2024 (USD Million)
TABLE 35 U.S. lab-on-a-chip market forecast, by application, 2016 - 2024 (USD Million)
TABLE 36 U.S. protein chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 37 U.S. protein chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 38 U.S. other market estimates, by application, 2013 - 2024 (USD Million)
TABLE 39 U.S. other market forecast, by application, 2016 - 2024 (USD Million)
TABLE 40 U.S. biochip market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 41 U.S. biochip market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 42 U.S. biotechnology and pharmaceutical companies market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 43 U.S. biotechnology and pharmaceutical companies market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 44 U.S. hospitals and diagnostics centers market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 45 U.S. hospitals and diagnostics centers market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 46 U.S. academic & research institutes market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 47 U.S. academic & research institutes market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 48 U.S. others market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 49 U.S. others market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 50 Canada biochip market estimates, by type, 2013 - 2024 (USD Million)
TABLE 51 Canada biochip market forecast, by type, 2016 - 2024 (USD Million)
TABLE 52 Canada DNA chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 53 Canada DNA chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 54 Canada lab-on-a-chip market estimates, by application, 2013 - 2024 (USD Million)
TABLE 55 Canada lab-on-a-chip market forecast, by application, 2016 - 2024 (USD Million)
TABLE 56 Canada protein chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 57 Canada protein chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 58 Canada other market estimates, by application, 2013 - 2024 (USD Million)
TABLE 59 Canada other market forecast, by application, 2016 - 2024 (USD Million)
TABLE 60 Canada biochip market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 61 Canada biochip market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 62 Canada biotechnology and pharmaceutical companies market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 63 Canada biotechnology and pharmaceutical companies market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 64 Canada hospitals and diagnostics centers market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 65 Canada hospitals and diagnostics centers market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 66 Canada academic & research institutes market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 67 Canada academic & research institutes market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 68 Canada others market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 69 Canada others market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 70 Europe biochip market estimates, by type, 2013 - 2024 (USD Million)
TABLE 71 Europe biochip market forecast, by type, 2016 - 2024 (USD Million)
TABLE 72 Europe DNA chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 73 Europe DNA chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 74 Europe lab-on-a-chip market estimates, by application, 2013 - 2024 (USD Million)
TABLE 75 Europe lab-on-a-chip market forecast, by application, 2016 - 2024 (USD Million)
TABLE 76 Europe protein chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 77 Europe protein chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 78 Europe other market estimates, by application, 2013 - 2024 (USD Million)
TABLE 79 Europe other market forecast, by application, 2016 - 2024 (USD Million)
TABLE 80 Europe biochip market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 81 Europe biochip market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 82 Europe biotechnology and pharmaceutical companies market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 83 Europe biotechnology and pharmaceutical companies market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 84 Europe hospitals and diagnostics centers market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 85 Europe hospitals and diagnostics centers market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 86 Europe academic & research institutes market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 87 Europe academic & research institutes market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 88 Europe others market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 89 Europe others market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 90 Germany biochip market estimates, by type, 2013 - 2024 (USD Million)
TABLE 91 Germany biochip market forecast, by type, 2016 - 2024 (USD Million)
TABLE 92 Germany DNA chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 93 Germany DNA chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 94 Germany lab-on-a-chip market estimates, by application, 2013 - 2024 (USD Million)
TABLE 95 Germany lab-on-a-chip market forecast, by application, 2016 - 2024 (USD Million)
TABLE 96 Germany protein chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 97 Germany protein chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 98 Germany other market estimates, by application, 2013 - 2024 (USD Million)
TABLE 99 Germany other market forecast, by application, 2016 - 2024 (USD Million)
TABLE 100 Germany biochip market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 101 Germany biochip market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 102 Germany biotechnology and pharmaceutical companies market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 103 Germany biotechnology and pharmaceutical companies market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 104 Germany hospitals and diagnostics centers market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 105 Germany hospitals and diagnostics centers market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 106 Germany academic & research institutes market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 107 Germany academic & research institutes market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 108 Germany others market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 109 Germany others market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 110 UK biochip market estimates, by type, 2013 - 2024 (USD Million)
TABLE 111 UK biochip market forecast, by type, 2016 - 2024 (USD Million)
TABLE 112 UK DNA chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 113 UK DNA chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 114 UK lab-on-a-chip market estimates, by application, 2013 - 2024 (USD Million)
TABLE 115 UK lab-on-a-chip market forecast, by application, 2016 - 2024 (USD Million)
TABLE 116 UK protein chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 117 UK protein chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 118 UK other market estimates, by application, 2013 - 2024 (USD Million)
TABLE 119 UK other market forecast, by application, 2016 - 2024 (USD Million)
TABLE 120 UK biochip market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 121 UK biochip market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 122 UK biotechnology and pharmaceutical companies market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 123 UK biotechnology and pharmaceutical companies market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 124 UK hospitals and diagnostics centers market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 125 UK hospitals and diagnostics centers market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 126 UK academic & research institutes market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 127 UK academic & research institutes market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 128 UK others market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 129 UK others market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 130 Asia Pacific biochip market estimates, by type, 2013 - 2024 (USD Million)
TABLE 131 Asia Pacific biochip market forecast, by type, 2016 - 2024 (USD Million)
TABLE 132 Asia Pacific DNA chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 133 Asia Pacific DNA chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 134 Asia Pacific lab-on-a-chip market estimates, by application, 2013 - 2024 (USD Million)
TABLE 135 Asia Pacific lab-on-a-chip market forecast, by application, 2016 - 2024 (USD Million)
TABLE 136 Asia Pacific protein chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 137 Asia Pacific protein chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 138 Asia Pacific other market estimates, by application, 2013 - 2024 (USD Million)
TABLE 139 Asia Pacific other market forecast, by application, 2016 - 2024 (USD Million)
TABLE 140 Asia Pacific biochip market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 141 Asia Pacific biochip market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 142 Asia Pacific biotechnology and pharmaceutical companies market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 143 Asia Pacific biotechnology and pharmaceutical companies market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 144 Asia Pacific hospitals and diagnostics centers market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 145 Asia Pacific hospitals and diagnostics centers market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 146 Asia Pacific academic & research institutes market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 147 Asia Pacific academic & research institutes market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 148 Asia Pacific others market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 149 Asia Pacific others market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 150 China biochip market estimates, by type, 2013 - 2024 (USD Million)
TABLE 151 China biochip market forecast, by type, 2016 - 2024 (USD Million)
TABLE 152 China DNA chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 153 China DNA chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 154 China lab-on-a-chip market estimates, by application, 2013 - 2024 (USD Million)
TABLE 155 China lab-on-a-chip market forecast, by application, 2016 - 2024 (USD Million)
TABLE 156 China protein chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 157 China protein chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 158 China other market estimates, by application, 2013 - 2024 (USD Million)
TABLE 159 China other market forecast, by application, 2016 - 2024 (USD Million)
TABLE 160 China biochip market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 161 China biochip market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 162 China biotechnology and pharmaceutical companies market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 163 China biotechnology and pharmaceutical companies market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 164 China hospitals and diagnostics centers market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 165 China hospitals and diagnostics centers market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 166 China academic & research institutes market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 167 China academic & research institutes market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 168 China others market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 169 China others market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 170 Japan biochip market estimates, by type, 2013 - 2024 (USD Million)
TABLE 171 Japan biochip market forecast, by type, 2016 - 2024 (USD Million)
TABLE 172 Japan DNA chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 173 Japan DNA chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 174 Japan lab-on-a-chip market estimates, by application, 2013 - 2024 (USD Million)
TABLE 175 Japan lab-on-a-chip market forecast, by application, 2016 - 2024 (USD Million)
TABLE 176 Japan protein chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 177 Japan protein chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 178 Japan other market estimates, by application, 2013 - 2024 (USD Million)
TABLE 179 Japan other market forecast, by application, 2016 - 2024 (USD Million)
TABLE 180 Japan biochip market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 181 Japan biochip market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 182 Japan biotechnology and pharmaceutical companies market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 183 Japan biotechnology and pharmaceutical companies market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 184 Japan hospitals and diagnostics centers market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 185 Japan hospitals and diagnostics centers market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 186 Japan academic & research institutes market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 187 Japan academic & research institutes market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 188 Japan others market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 189 Japan others market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 190 Latin America biochip market estimates, by type, 2013 - 2024 (USD Million)
TABLE 191 Latin America biochip market forecast, by type, 2016 - 2024 (USD Million)
TABLE 192 Latin America DNA chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 193 Latin America DNA chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 194 Latin America lab-on-a-chip market estimates, by application, 2013 - 2024 (USD Million)
TABLE 195 Latin America lab-on-a-chip market forecast, by application, 2016 - 2024 (USD Million)
TABLE 196 Latin America protein chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 197 Latin America protein chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 198 Latin America other market estimates, by application, 2013 - 2024 (USD Million)
TABLE 199 Latin America other market forecast, by application, 2016 - 2024 (USD Million)
TABLE 200 Latin America biochip market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 201 Latin America biochip market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 202 Latin America biotechnology and pharmaceutical companies market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 203 Latin America biotechnology and pharmaceutical companies market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 204 Latin America hospitals and diagnostics centers market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 205 Latin America hospitals and diagnostics centers market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 206 Latin America academic & research institutes market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 207 Latin America academic & research institutes market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 208 Latin America others market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 209 Latin America others market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 210 Brazil biochip market estimates, by type, 2013 - 2024 (USD Million)
TABLE 211 Brazil biochip market forecast, by type, 2016 - 2024 (USD Million)
TABLE 212 Brazil DNA chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 213 Brazil DNA chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 214 Brazil lab-on-a-chip market estimates, by application, 2013 - 2024 (USD Million)
TABLE 215 Brazil lab-on-a-chip market forecast, by application, 2016 - 2024 (USD Million)
TABLE 216 Brazil protein chips market estimates, by application, 2013 - 2024 (USD Million)
TABLE 217 Brazil protein chips market forecast, by application, 2016 - 2024 (USD Million)
TABLE 218 Brazil other market estimates, by application, 2013 - 2024 (USD Million)
TABLE 219 Brazil other market forecast, by application, 2016 - 2024 (USD Million)
TABLE 220 Brazil biochip market estimate, by end use, 2013 - 2024 (USD Million)
TABLE 221 Brazil biochip market forecast, by end use, 2016 - 2024 (USD Million)
TABLE 222 Brazil biotechnology and pharmaceutical companies market estimate, by end use, 2013 - 2024 (USD Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report